An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia-Reference-Cited by-同舟云学术

An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia

Published:2014-01-28 Issue:6 Volume:17 Page:679-686
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Huang Xinfang¹,Du Hui¹,Gu Jieruo²,Zhao Dongbao³,Jiang Lindi⁴,Li Xinfu⁵,Zuo Xiaoxia⁶,Liu Yi⁷,Li Zhanguo⁸,Li Xiangpei⁹,Zhu Ping¹⁰,Li Juan¹¹,Zhang Zhiyi¹²,Huang Anbin¹³,Zhang Yuanchao¹⁴,Bao Chunde¹

Affiliation:

1. Ren Ji Hospital; School of Medicine; Shanghai Jiao Tong University; Shanghai China

2. The Third Affiliated Hospital of Sun Yat-sen University; Guangzhou China

3. Changhai Hospital; Affiliated to Second Military Medical University; Shanghai China

4. Zhongshan Hospital; Affiliated to Fudan University; Shanghai China

5. Qilu Hospital; Affiliated to Shandong University; Jinan China

6. Xiangya Hospital; Central-South University; Changsha China

7. Huaxi Hospital; Affiliated to Sichuan University; Chengdu China

8. Peking University People's Hospital; Beijing China

9. Anhui Provincial Hospital; Hefei China

10. Xijing Hospital; Fourth Military Medical University; Xi'an China

11. Southern Medical University South Hospital; Huangzhou China

12. First Affiliated Hospital of Harbin Medical University; Harbin China

13. Wuhan Union Hospital; Tongji Medical College; Huazhong University of Science and Technology; Wuhan China

14. Shandong Provincial Hospital; Qingdao China

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1756-185X.12266/fullpdf

Reference26 articles.

1. Gout and hyperuricemia;Wortmann;Curr Opin Rheumatol,2002

2. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout;Perez-Ruiz;Ann Rheum Dis,1998

3. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout;Perez-Ruiz;Arthritis Rheum,2002

4. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy;Shoji;Arthritis Rheum,2004

5. Correlations among hyperuricemia, hypercholesterolemia, coronary disease and hypertension;Hall;Arthritis Rheum,1965

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperuricemia and its related diseases: mechanisms and advances in therapy;Signal Transduction and Targeted Therapy;2024-08-28

2. J-shaped association of serum uric acid concentrations with all-cause mortality in individuals with osteoarthritis: A prospective cohort study;Joint Bone Spine;2024-05

3. Comparative Risk of Gout Flares When Initiating or Escalating Various Urate‐Lowering Therapy: A Systematic Review With Network Meta‐Analysis;Arthritis Care & Research;2024-03-14

4. Comparison of clinical and economic evaluation between selected generic and original febuxostat tablets in Chinese gout patients with hyperuricemia: A real-world multicenter retrospective study;Medicine;2024-01-26

5. Cardiovascular Safety of Febuxostat in Patients With Gout or Hyperuricemia;JCR: Journal of Clinical Rheumatology;2023-12-20